ARTICLE | Clinical News
EP217609: Phase IIa started
June 27, 2011 7:00 AM UTC
Endotis began the Phase IIa NOVEL trial to compare EP217609 and its specific antidote avidin vs. heparin in 36 patients undergoing cardiac surgery. Endotis has rights to EP217609 from Merck. ...